PFAS, including PFOA and PFOS, continue infiltrating our environment, with over 98% of the US population displaying detectable levels in their blood. Researchers continue to study Forever Chemicals for their link to kidney cancer. This prompted Dr. Jonathan Hofmann and his team to lead a comprehensive study in 2020. The groundbreaking research, published in the Journal of the National Cancer Institute, examines the relationship between PFAS exposure and kidney cancer risk.

The 2020 Study: Investigating PFAS and Cancer
In their extensive study, Dr. Hofmann and colleagues utilized data from the PLCO Cancer Screening Trial. By measuring PFAS levels in blood samples collected before cancer diagnosis, the researchers aimed to minimize bias and gain a deeper understanding of the association between PFAS and kidney cancer. The findings were alarming—participants with the highest concentrations of perfluorooctanoic acid (PFOA), a prominent PFAS, were more than twice as likely to develop kidney cancer.
Race and Kidney Cancer Risk
Recognizing the need for a more diverse perspective, the researchers extended their investigation to race and ethnicity. This additional segment of the study, published in Environment International, offered valuable insights into the varied associations between PFAS and kidney cancer risk among different racial and ethnic groups. A distinct positive link emerged among non-Hispanic White participants, echoing the PLCO findings.
African Americans at Higher Risk
Intriguingly, the study also revealed that higher levels of PFNA, another frequently detected PFAS, were associated with an increased risk of kidney cancer. This association was most pronounced among African American participants. The elevated PFNA and perfluorooctane sulfonate (PFOS) concentrations in Black participants compared to White counterparts highlighted the disparities in PFAS exposure.
Kidney Cancer and PFAS Exposure: What Do I Do?
Not only does this study show PFAS exposure can cause kidney cancer but also emphasize the need to protect diverse populations and at-risk occupations. We can channel this knowledge into actionable steps—raising awareness, implementing preventive measures, and advocating for policies that safeguard vulnerable communities and occupational groups. Additionally, more than 5,000 people with kidney cancer have filed lawsuits to seek compensation for their injuries. They seek to hold 3M and DuPont, producers of PFAS, accountable by proving these chemicals caused their kidney cancer. By staying informed and actively addressing these challenges, we pave the way for a healthier, safer future for all.